SEC Filing Details
Document Details
Form
Filing Date
Sep 21, 2017
Document Date
Sep 19, 2017
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Nektar Therapeutics
Issuer
NEKTAR THERAPEUTICS
Filer
Ajer Jeffrey Robert